Market Research

Primary Biliary Cholangitis Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Primary Biliary Cholangitis Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Primary Biliary Cholangitis Market:

https://www.thebusinessresearchcompany.com/report/primary-biliary-cholangitis-global-market-report

According to The Business Research Company’s Primary Biliary Cholangitis Global Market Report 2024, The primary biliary cholangitis market size has grown rapidly in recent years. It will grow from $0.87 billion in 2023 to $0.98 billion in 2024 at a compound annual growth rate (CAGR) of 12.1%. The  growth in the historic period can be attributed to increased disease awareness, rising global healthcare expenditure, strategic collaborations in the healthcare sector, focus on patient advocacy, government initiatives for liver health..

The primary biliary cholangitis market size is expected to see rapid growth in the next few years. It will grow to $1.46 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to expansion of biomarker research, global efforts in rare disease management, increased collaboration in clinical trials, patient-centric healthcare approaches, rising demand for liver transplants.. Major trends in the forecast period include advancements in biomarker research, growing emphasis on non-invasive diagnostic techniques, research focus on immunomodulatory therapies, integration of artificial intelligence (ai), patient-reported outcomes in clinical trials, telemedicine for patient management, focus on combination therapies, emerging therapies targeting fibrosis..

The increase in smoking is expected to propel the growth of the primary biliary cholangitis market going forward. Smoking refers to the act of inhaling and exhaling the smoke produced by burning tobacco or other substances. Smoking is a known risk factor for liver diseases, including PBC, and higher smoking rates can lead to more individuals seeking medical attention for liver-related issues. For instance, in July 2023, according to Statistics Canada, a Canada-based government agency, cigarette production increased by 2.2% compared to June 2023 in Canada. Moreover, there was a 2.6% rise in cigarette sales in June, reaching 1.4 billion units compared to May. Therefore, the increase in smoking will drive the growth of the primary biliary cholangitis market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=13520&type=smp

The primary biliary cholangitis market covered in this report is segmented –

1) By Treatment Type: Drugs, Liver Transplantation

2) By Diagnosis:  Imaging Tests, Magnetic Resonance Elastography (MRE), Magnetic Resonance Cholangiopancreatography (MRCP), Ultrasound, Fibroscan, Blood Tests, Cholesterol Test, Antibody Tests, Liver Tests, Other Diagnoses

3) By End-Users: Specialty Clinics, Homecare, Other End-Users

Companies operating in the primary biliary cholangitis market are focused on developing innovative and specialized treatments, such as orphan drugs with a combination of obeticholic acid (OCA) and bezafibrates to treat primary biliary cholangitis (PBC), to gain market exclusivity. The combination of OCA and bezafibrate with an orphan drug designation aims to offer a more comprehensive and effective approach to managing PBC treatment, potentially improving the quality of life for individuals affected by this rare condition. For instance, in May 2023, Intercept Pharmaceuticals, Inc., a US-based biopharmaceutical company, received orphan drug designation from the FDA for the combination of obeticholic acid (OCA) and bezafibrate, a PPAR agonist, as a potential treatment for primary biliary cholangitis (PBC), a progressive liver disease, and obeticholic acid (marketed as Ocaliva) is approved for PBC in the US.

The primary biliary cholangitis market report table of contents includes:

 

  1. Executive Summary
  2. Primary Biliary Cholangitis Market Characteristics
  3. Primary Biliary Cholangitis Market Trends And Strategies
  4. Primary Biliary Cholangitis Market – Macro Economic Scenario
  5. Global Primary Biliary Cholangitis Market Size and Growth

.

.

.

  1. Global Primary Biliary Cholangitis Market Competitive Benchmarking
  2. Global Primary Biliary Cholangitis Market Competitive Dashboard
  3. Key Mergers And Acquisitions In The Primary Biliary Cholangitis Market
  4. Primary Biliary Cholangitis Market Future Outlook and Potential Analysis
  5. Appendix

Top Major Players:

  • Pfizer Inc.
  • Hoffmann-La Roche Ltd
  • Novartis AG
  • Bristol-Myers Squibb Company
  • AstraZeneca PLC

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company  

Twitter: https://twitter.com/tbrc_info  

Facebook: https://www.facebook.com/TheBusinessResearchCompany  

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ   

Blog: https://blog.tbrc.info/  

Healthcare Blog: https://healthcareresearchreports.com/  

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Good PR News

Recent Posts

Hazelnut Market Outlook 2024-2033: Trends and Projections

Market Size - The hazelnut market size has grown strongly in recent years. It will…

9 hours ago

IoT Gateway Devices Market Expansion 2024-2033: Growth Drivers and Dynamics

Market Size - The IoT gateway devices market size has grown rapidly in recent years.…

9 hours ago

Zinc Rich Coating Market Outlook 2024-2033: Trends and Projections

Market Size - The zinc rich coating market size has grown rapidly in recent years.…

9 hours ago

Time-Sensitive Networking (TSN) Market Outlook 2024-2033: Trends and Projections

Market Size - The time-sensitive networking (TSN) market size has grown exponentially in recent years.…

9 hours ago